ProfileGDS4284 / 210258_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 29% 23% 28% 2% 17% 42% 20% 19% 55% 96% 1% 2% 28% 98% 28% 19% 31% 22% 1% 0% 4% 15% 16% 52% 46% 28% 24% 54% 17% 20% 55% 97% 21% 7% 1% 97% 9% 23% 0% 1% 1% 96% 24% 19% 26% 0% 98% 31% 1% 14% 1% 98% 1% 3% 21% 27% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control66.947629
GSM687648Patient 402 control49.148723
GSM687653Patient 403 control64.771428
GSM687658Patient 404 control6.762212
GSM687663Patient 411 control33.482617
GSM687668Patient 422 control140.82542
GSM687673Patient 424 control43.16920
GSM687678Patient 425 control41.599919
GSM687683Patient 427 control314.0655
GSM687688Patient 428 control8469.6296
GSM687695Patient 441 control7.186521
GSM687699Patient 443 control6.339252
GSM687704Patient 444 control68.916528
GSM687707Patient 448 control15108.998
GSM687712Patient 449 control70.950328
GSM687719Patient 450 control45.501719
GSM687724Patient 451 control100.26131
GSM687728Patient 452 control52.091922
GSM687646Patient 401 treated 24h3.140041
GSM687649Patient 402 treated 24h1.827130
GSM687665Patient 411 treated 24h9.859264
GSM687651Patient 402 treated 4 weeks26.426715
GSM687667Patient 411 treated 4 weeks30.919416
GSM687670Patient 422 treated 24h266.46752
GSM687671Patient 422 treated 4 weeks168.76546
GSM687654Patient 403 treated 24h63.836828
GSM687675Patient 424 treated 24h62.75624
GSM687685Patient 427 treated 24h281.19154
GSM687656Patient 403 treated 4 weeks27.041117
GSM687677Patient 424 treated 4 weeks39.51720
GSM687687Patient 427 treated 4 weeks288.42855
GSM687692Patient 428 treated 4h9930.0897
GSM687716Patient 449 treated 4h45.912121
GSM687722Patient 450 treated 4h15.68957
GSM687680Patient 425 treated 24h3.703751
GSM687690Patient 428 treated 24h11563.997
GSM687700Patient 443 treated 24h27.60379
GSM687705Patient 444 treated 24h46.048623
GSM687714Patient 449 treated 24h0.8875350
GSM687721Patient 450 treated 24h3.875511
GSM687682Patient 425 treated 4 weeks4.048091
GSM687694Patient 428 treated 4 weeks7953.4396
GSM687702Patient 443 treated 4 weeks60.786724
GSM687718Patient 449 treated 4 weeks39.202219
GSM687723Patient 450 treated 4 weeks65.130426
GSM687661Patient 404 treated 4h1.682920
GSM687710Patient 448 treated 4h13853.998
GSM687726Patient 451 treated 4h96.950431
GSM687730Patient 452 treated 4h17.03531
GSM687660Patient 404 treated 24h36.84114
GSM687697Patient 441 treated 24h4.87941
GSM687709Patient 448 treated 24h15791.398
GSM687725Patient 451 treated 24h5.169791
GSM687729Patient 452 treated 24h11.73443
GSM687727Patient 451 treated 4 weeks52.182821
GSM687731Patient 452 treated 4 weeks76.298127